GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 207 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $43,523,000 | +5961.7% | 639,097 | +3529.2% | 0.20% | +6633.3% |
| Q1 2021 | $718,000 | -78.8% | 17,610 | -77.5% | 0.00% | -80.0% |
| Q4 2020 | $3,385,000 | +33.2% | 78,153 | +69.5% | 0.02% | +50.0% |
| Q3 2020 | $2,542,000 | -47.3% | 46,101 | -39.6% | 0.01% | -58.3% |
| Q2 2020 | $4,820,000 | +883.7% | 76,357 | +695.4% | 0.02% | +700.0% |
| Q1 2020 | $490,000 | -62.8% | 9,600 | -42.0% | 0.00% | -25.0% |
| Q4 2019 | $1,317,000 | -50.7% | 16,565 | -69.9% | 0.00% | -60.0% |
| Q3 2019 | $2,671,000 | +29.8% | 55,053 | +41.6% | 0.01% | +25.0% |
| Q1 2019 | $2,058,000 | +586.0% | 38,887 | +392.2% | 0.01% | +700.0% |
| Q3 2018 | $300,000 | -25.6% | 7,901 | -11.5% | 0.00% | -50.0% |
| Q2 2018 | $403,000 | -71.3% | 8,928 | -69.2% | 0.00% | -66.7% |
| Q1 2018 | $1,402,000 | – | 29,022 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |